NCT01138176

Brief Summary

A prospective randomized control trial to examine safety and effectiveness of whole body cooling to a rectal temperature of 33.5 C using phase changing material in neonatal encephalopathy. Effectiveness will be defined by examining the stability of rectal temperature during cooling. Monitoring of vital signs, infection screen, blood counts, coagulation screen, liver and renal function tests, cranial US and MR imaging will be performed on recruited infants to evaluate safety of cooling. EEG will be performed on day 4 and hearing evaluation at discharge. Neurodevelopmental evaluation will be performed at 1 year of age.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Jul 2009

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 2, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 7, 2010

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
Last Updated

June 7, 2010

Status Verified

June 1, 2010

Enrollment Period

1.5 years

First QC Date

June 2, 2010

Last Update Submit

June 3, 2010

Conditions

Keywords

Neonatal encephalopathyTherapeutic hypothermiaPhase changing materialMR imaging

Outcome Measures

Primary Outcomes (1)

  • Stability of cooling

    Percentage of time for which rectal temperature is maintained between 33 to 34 C during the 72 hours of therapeutic hypothermia

    72 hours

Secondary Outcomes (5)

  • Brain tissue injury on MR imaging

    7 to 10 days

  • Adverse neurodevelopment

    12 months

  • Mortality

    4 weeks

  • EEG abnormality

    4 days

  • Sepsis

    1 week

Study Arms (2)

Standard care

NO INTERVENTION
Procedure: Cooling

Cooling

EXPERIMENTAL

Reduction of rectal temperature to 33.5 C for 72 hours

Procedure: Cooling

Interventions

CoolingPROCEDURE

Reduction of rectal temperature to 33.5 C

Also known as: Therapeutic hypothermia, Whole body cooling
CoolingStandard care

Eligibility Criteria

AgeUp to 24 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Apgar score of \<5 at 5 minutes or continued resuscitation at 5 minutes
  • Neonatal encephalopathy

You may not qualify if:

  • Imminent death
  • Major congenital malformations
  • Gestation \<36 weeks
  • Birthweight less than 1.8 kg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Calicut Medical College

Calicut, India

Location

Related Links

MeSH Terms

Conditions

Hypoxia-Ischemia, Brain

Interventions

Cool-Down ExerciseHypothermia, Induced

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Post-Exercise Recovery TechniquesPhysical Therapy ModalitiesTherapeuticsRehabilitationExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaCryotherapy

Study Officials

  • Balraj Guhan, MD

    Calicut Medical College

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDIV

Study Record Dates

First Submitted

June 2, 2010

First Posted

June 7, 2010

Study Start

July 1, 2009

Primary Completion

January 1, 2011

Study Completion

August 1, 2011

Last Updated

June 7, 2010

Record last verified: 2010-06

Locations